Evidence map›Paper›PMID 33574421›Full record

ArticleScientific reports2021

Impact of synbiotics on gut microbiota during early life: a randomized, double-blind study.

Nopaorn Phavichitr, Shugui Wang, Sirinuch Chomto, Ruangvith Tantibhaedhyangkul, Alexia Kakourou, Sukkrawan Intarakhao, Sungkom Jongpiputvanich, COLOR Study Group, Guus Roeselers, Jan Knol

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 5 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 5 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Diagnosing and engineering gut microbiomes.EMBO molecular medicine · 2024
    Review
  18. Article
  19. Microbes as medicine.Annals of the New York Academy of Sciences · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Nopaorn Phavichitr *Department of Paediatrics, Phramongkutklao Hospital, Bangkok, Thailand.
Shugui WangDanone Nutricia Research, Singapore, Singapore.
Sirinuch ChomtoNutritional Unit, Department of Pediatrics, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand.
Ruangvith TantibhaedhyangkulDepartment of Paediatrics, Phramongkutklao Hospital, Bangkok, Thailand.
Alexia KakourouDanone Nutricia Research, Utrecht, The Netherlands.
Sukkrawan IntarakhaoDepartment of Pediatrics, Thammasat Hospital, Faculty of Medicine, Thammasat University, Bangkok, Thailand.
Sungkom JongpiputvanichDepartment of Pediatrics, Thammasat Hospital, Faculty of Medicine, Thammasat University, Bangkok, Thailand.
COLOR Study Group
Guus RoeselersDanone Nutricia Research, Utrecht, The Netherlands. guus.roeselers@danone.com.
Jan KnolDanone Nutricia Research, Utrecht, The Netherlands.
Chulalongkorn University · THDanone (Netherlands) · NLPhramongkutklao Hospital · THThammasat University Hospital · THNutricia Research (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human milk is considered the optimal nutrition for infants and found to contain significant numbers of viable bacteria. The aim of the study was to assess the effects of a specific synbiotic combination at doses closer to the bacterial cells present in human milk, on intestinal bifidobacteria proportions (relative abundance), reduction of potential pathogens and gut physiological conditions. A clinical study was conducted in 290 healthy infants aged from 6 to 19 weeks. Infants received either a control infant formula or one of the two investigational infant formulas (control formula with 0.8 g/100 ml scGOS/lcFOS and Bifidobacterium breve M-16V at either 1 × 10

Indexed as

Bacterial InfectionsBifidobacteriumBifidobacterium breveBreast FeedingClostridioides difficileDouble-Blind MethodFecesFemaleGastrointestinal MicrobiomeHumansInfantInfant FormulaInfant, NewbornMaleMilk, HumanSynbiotics

Identifiers

PMID33574421
PMCPMC7878856
OpenAlexW3128886743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.